Press release
Transcat, Inc. Provides Business Update Due to COVID-19
ROCHESTER, N.Y.--(BUSINESS WIRE)-- Transcat, Inc. (Nasdaq: TRNS) (“Transcat” or the “Company”), a leading provider of accredited calibration, repair,
About this update from Transcat, Inc.
[{"type":"text","content":" ROCHESTER, N.Y.--(BUSINESS WIRE)--\nTranscat, Inc. (Nasdaq: TRNS) (“Transcat” or the “Company”), a leading provider of accredited calibration, repair, inspection and laboratory instrument services and value-added distributor of professional grade handheld test, measurement and control instrumentation, provided an update on its operations and actions to address the COVID-19 pandemic.\n\n\nGiven the critical nature of the services and products that Transcat provides, its calibration labs, distribution center and support offices currently remain fully operational.\n\n\nTranscat has implemented a number of actions in accordance with federal, state and local mandates to limit the spread of COVID-19 and to protect the health and safety of its employees, customers and partners. Those actions include enhanced sanitizing procedures, social distancing and remote working, travel and visitor restrictions, and new shipping and receiving protocols. The Company will continue to monitor industry conditions and implement appropriate measures to address this fluid situation.\n\n\nLee D. Rudow, Transcat’s President and CEO, commented, “The safety and well-being of our employees, customers and the communities we serve remain top priorities. I want to thank all of our associates for their tireless efforts in keeping our operations running. Quality calibration and laboratory instrument services are a critical component of our customers’ business operations, particularly those in highly-regulated industries, such as life sciences, a market that comprises nearly half of our Service segment business. Among many critical applications, last week we were onboard the USNS Comfort, the world’s largest hospital ship, calibrating critical respirator supply systems before that ship set sail to New York City to serve as a floating hospital in that COVID-19 epicenter. We also have medical device customers manufacturing life-saving devices including ventilators and personal protection equipment, and pharmaceutical customers who are actively working on vaccines and COVID-19 test kits to help combat this pandemic. Transcat is committed to responding with actions to ensure that there is continuity of support through this global crisis.”\n\n\nMr. Rudow added, “There is little doubt that COVID-19 will negatively impact the global economy. Even Transcat, despite our co...